A form of heart failure known as heart failure with preserved ejection fraction (HFpEF, pronounced “hefpef”) is becoming more common but remains poorly understood. No effective treatment options exist. Women are twice as likely to suffer from HFpEF as men, but the reasons for this are also unclear

In the United States, comparative rankings of hospitals based on the quality of their cardiovascular (CV) care are easily available online and in the mainstream media. In Canada, this information is almost entirely unavailable, but a new joint initiative of the Canadian Cardiovascular Society (CCS)

A number of Ottawa Heart Institute staff and trainees were honoured at this year’s Canadian Cardiovascular Congress, recognizing their accomplishments at both early and established phases of their careers. Canadian Cardiovascular Society (CCS) Research Achievement Award Rob Beanlands, Chief of

Cancer and heart disease are the two leading causes of death. As we live longer lives, we are more likely to eventually have one or the other. But for many cancer patients, treatment of their condition makes it much more likely that they will have to deal with both. More people are surviving cancer

Many of the patients admitted to hospital with a STEMI heart attack (ST-elevation myocardial infarction) have major blockages in blood vessels other than the one directly responsible for the heart attack. The best strategy for treating these patients remains an open question for cardiologists

The American Heart Association Scientific Sessions is the largest conference for cardiovascular science and medicine in the world. The staff of the University of Ottawa Heart Institute is once again responsible for many expert clinical talks and research presentations. This guide highlights those